{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:41Z","timestamp":1791216041003,"version":"4.1.0"},"reference-count":38,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2023,6,16]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Fabry disease (FD) is an X-linked lysosomal storage disorder caused by enzyme deficiency, leading to glycosphingolipid accumulation. Cardiac accumulation triggers local tissue injury, electrical instability and arrhythmia. Bradyarrhythmia and atrial fibrillation (AF) incidence are reported in up to 16% and 13%, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We conducted a systematic review evaluating AF burden and bradycardia requiring permanent pacemaker (PPM) implantation and report any predictive risk factors identified.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a literature search on studies in adults with FD published from inception to July 2019. Study outcomes included AF or bradycardia requiring therapy. Databases included Embase, Medline, PubMed, Web of Science, CINAHL and Cochrane. The Risk of Bias Agreement tool for Non-Randomised Studies (RoBANS) was utilised to assess bias across key areas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>11 studies were included, eight providing data on AF incidence or PPM implantation. Weighted estimate of event rates for AF were 12.2% and 10% for PPM. Age was associated with AF (OR 1.05\u20131.20 per 1-year increase in age) and a risk factor for PPM implantation (composite OR 1.03). Left ventricular hypertrophy (LVH) was associated with AF and PPM implantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Evidence supporting AF and bradycardia requiring pacemaker implantation is limited to single-centre studies. Incidence is variable and choice of diagnostic modality plays a role in detection rate. Predictors for AF (age, LVH and atrial dilatation) and PPM (age, LVH and PR\/QRS interval) were identified but strength of association was low. Incidence of AF and PPM implantation in FD are variably reported with arrhythmia burden likely much higher than previously thought.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO database<\/jats:title>\n                  <jats:p>CRD42019132045.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2023-002316","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T21:10:30Z","timestamp":1689628230000},"page":"e002316","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease"],"prefix":"10.1136","volume":"10","author":[{"given":"Ravi","family":"Vijapurapu","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"},{"name":"Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4600-2733","authenticated-orcid":false,"given":"Ashwin","family":"Roy","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyvios","family":"Demetriades","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Warfield","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn A","family":"Hughes","sequence":"additional","affiliation":[{"name":"University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saint Bartholomew's Hospital Barts Heart Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Woolfson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Salford Royal Hospital, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"de Bono","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarekegn","family":"Geberhiwot","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Queen Elizabeth Hospital, Birmingham, UK"},{"name":"University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-9812","authenticated-orcid":false,"given":"Dipak","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5687-2535","authenticated-orcid":false,"given":"Richard Paul","family":"Steeds","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"},{"name":"Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"2025081710233262000_10.2.e002316.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-4-200302180-00014"},{"key":"2025081710233262000_10.2.e002316.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61589-5"},{"key":"2025081710233262000_10.2.e002316.3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq117"},{"key":"2025081710233262000_10.2.e002316.4","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.065904"},{"key":"2025081710233262000_10.2.e002316.5","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012428009627"},{"key":"2025081710233262000_10.2.e002316.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.114.002569"},{"key":"2025081710233262000_10.2.e002316.7","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.063818"},{"key":"2025081710233262000_10.2.e002316.8","doi-asserted-by":"crossref","first-page":"f153","DOI":"10.1093\/europace\/eux261","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","volume":"20","author":"Baig","year":"2018","journal-title":"Europace"},{"key":"2025081710233262000_10.2.e002316.9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025081710233262000_10.2.e002316.10","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eur267"},{"key":"2025081710233262000_10.2.e002316.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm153"},{"key":"2025081710233262000_10.2.e002316.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.10.056"},{"key":"2025081710233262000_10.2.e002316.13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.22047","article-title":"Arrhythmias in Fabry cardiomyopathy","volume":"35","author":"Acharya","year":"2012","journal-title":"Clin Cardiol"},{"key":"2025081710233262000_10.2.e002316.14","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-306782"},{"key":"2025081710233262000_10.2.e002316.15","unstructured":"Park J , Lee Y , Seo H , et al . Risk of bias assessment tool for non-randomised studies (RoBANS): Development and validation of a new instrument. Abstracts of the 19th Cochrane Colloquium. Madrid, Spain: John Wiley & Sons, 2011."},{"key":"2025081710233262000_10.2.e002316.16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/clc.23019","article-title":"Severe Bradyarrhythmia linked to left atrial dysfunction in Fabry disease-a cross-sectional study","volume":"41","author":"Di","year":"2018","journal-title":"Clin Cardiol"},{"key":"2025081710233262000_10.2.e002316.17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.echo.2016.10.014","article-title":"Impaired left atrial function in Fabry disease: a longitudinal speckle-tracking echocardiography study","volume":"30","author":"Pichette","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2025081710233262000_10.2.e002316.18","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004996","article-title":"Cardiac device implantation in Fabry disease: a retrospective Monocentric study","volume":"95","author":"Sen\u00e9","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025081710233262000_10.2.e002316.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.05.033"},{"key":"2025081710233262000_10.2.e002316.20","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-306278"},{"key":"2025081710233262000_10.2.e002316.21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjcard.2016.04.033","article-title":"Usefulness of an implantable loop recorder to detect clinically relevant arrhythmias in patients with advanced Fabry cardiomyopathy","volume":"118","author":"Weidemann","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025081710233262000_10.2.e002316.22","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315229"},{"key":"2025081710233262000_10.2.e002316.23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2016.06.007","article-title":"Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: data from the Fabry Registry","volume":"119","author":"Hopkin","year":"2016","journal-title":"Mol Genet Metab"},{"key":"2025081710233262000_10.2.e002316.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000740"},{"key":"2025081710233262000_10.2.e002316.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005119"},{"key":"2025081710233262000_10.2.e002316.26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv513"},{"key":"2025081710233262000_10.2.e002316.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.10.220"},{"key":"2025081710233262000_10.2.e002316.28","article-title":"Fabry disease and early stroke","volume":"2011","author":"Feldt-Rasmussen","year":"2011","journal-title":"Stroke Res Treat"},{"key":"2025081710233262000_10.2.e002316.29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy815"},{"key":"2025081710233262000_10.2.e002316.30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"2025081710233262000_10.2.e002316.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(03)00233-X","article-title":"A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope","volume":"115","author":"Sivakumaran","year":"2003","journal-title":"Am J Med"},{"key":"2025081710233262000_10.2.e002316.32","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux318"},{"key":"2025081710233262000_10.2.e002316.33","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0436"},{"key":"2025081710233262000_10.2.e002316.34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2864"},{"key":"2025081710233262000_10.2.e002316.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.060061"},{"key":"2025081710233262000_10.2.e002316.36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00392-018-1285-4","article-title":"Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke\/TIA in Fabry disease patients without atrial fibrillation","volume":"107","author":"Liu","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2025081710233262000_10.2.e002316.37","first-page":"104","article-title":"Acute decompensated heart failure after initiation of amiodarone in a patient with Anderson-Fabry disease","volume":"35","author":"Fine","year":"2019","journal-title":"Can J Cardiol"},{"key":"2025081710233262000_10.2.e002316.38","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3425-1","article-title":"A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (railroad) compared with current standard practice","volume":"20","author":"Vijapurapu","year":"2019","journal-title":"Trials"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2023-002316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:23:40Z","timestamp":1755451420000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2023-002316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,7,17]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/openhrt-2023-002316"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2023-002316","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}